Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 18 studies | 40% ± 20% | |
| lung | 14 studies | 23% ± 7% | |
| eye | 9 studies | 46% ± 15% | |
| peripheral blood | 7 studies | 26% ± 12% | |
| heart | 5 studies | 22% ± 4% | |
| kidney | 4 studies | 19% ± 6% | |
| liver | 4 studies | 30% ± 14% | |
| intestine | 4 studies | 24% ± 8% | |
| adipose | 4 studies | 26% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 19678.40 | 2642 / 2642 | 100% | 122.01 | 705 / 705 |
| esophagus | 100% | 21563.38 | 1445 / 1445 | 100% | 48.16 | 183 / 183 |
| ovary | 100% | 23360.42 | 180 / 180 | 100% | 43.75 | 430 / 430 |
| prostate | 100% | 19095.38 | 245 / 245 | 100% | 73.97 | 502 / 502 |
| lung | 100% | 20094.48 | 578 / 578 | 100% | 48.87 | 1154 / 1155 |
| kidney | 100% | 13939.17 | 89 / 89 | 100% | 69.83 | 899 / 901 |
| breast | 100% | 19108.13 | 459 / 459 | 100% | 63.97 | 1115 / 1118 |
| stomach | 100% | 14373.33 | 359 / 359 | 100% | 44.59 | 285 / 286 |
| bladder | 100% | 23510.86 | 21 / 21 | 100% | 50.13 | 502 / 504 |
| skin | 100% | 14408.72 | 1808 / 1809 | 100% | 68.57 | 470 / 472 |
| thymus | 100% | 16293.07 | 652 / 653 | 100% | 70.13 | 603 / 605 |
| intestine | 100% | 22293.42 | 966 / 966 | 99% | 45.13 | 524 / 527 |
| adrenal gland | 100% | 14169.91 | 258 / 258 | 99% | 60.74 | 227 / 230 |
| uterus | 100% | 23970.29 | 170 / 170 | 99% | 45.26 | 453 / 459 |
| pancreas | 97% | 6660.43 | 318 / 328 | 99% | 60.42 | 176 / 178 |
| liver | 99% | 6236.82 | 224 / 226 | 96% | 32.88 | 389 / 406 |
| adipose | 100% | 20274.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 27674.89 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 60.01 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 44.34 | 29 / 29 |
| muscle | 100% | 17065.60 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 18383.88 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 42.13 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 40.33 | 1 / 1 |
| heart | 100% | 13918.39 | 859 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 11503.08 | 916 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051016 | Biological process | barbed-end actin filament capping |
| GO_1903142 | Biological process | positive regulation of establishment of endothelial barrier |
| GO_0032092 | Biological process | positive regulation of protein binding |
| GO_1903393 | Biological process | positive regulation of adherens junction organization |
| GO_0071277 | Biological process | cellular response to calcium ion |
| GO_0051017 | Biological process | actin filament bundle assembly |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005829 | Cellular component | cytosol |
| GO_0005912 | Cellular component | adherens junction |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008290 | Cellular component | F-actin capping protein complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0030507 | Molecular function | spectrin binding |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0051015 | Molecular function | actin filament binding |
| GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
| GO_0003723 | Molecular function | RNA binding |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| GO_0005516 | Molecular function | calmodulin binding |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | ADD1 |
| Protein name | Adducin 1 Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 protein |
| Synonyms | ADDA |
| Description | FUNCTION: Membrane-cytoskeleton-associated protein that promotes the assembly of the spectrin-actin network. Binds to calmodulin. |
| Accessions | E7EV99 ENST00000264758.11 [P35611-3] ENST00000651918.1 [P35611-2] ENST00000511797.5 ENST00000398129.5 [P35611-1] ENST00000683351.1 D6RAH3 ENST00000503455.6 H0YFD8 A0A804HL01 ENST00000508277.5 D6RF25 H0Y9H2 Q96D30 ENST00000541843.2 E7ENY0 ENST00000355842.7 [P35611-4] D6RJE2 ENST00000513328.6 P35611 ENST00000514940.5 ENST00000536424.2 H0YG19 ENST00000398123.6 [P35611-6] ENST00000398125.5 [P35611-6] ENST00000510101.5 |